The Role of Metabolism in Heart Failure and Regeneration

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2021 Aug 2

PMID 34336958

Citations 19

Authors

Jiyoung Bae

Wyatt G Paltzer

Ahmed I Mahmoud

Affiliations

Soon will be listed here.

Abstract

Heart failure is the leading cause of death worldwide. The inability of the adult mammalian heart to regenerate following injury results in the development of systolic heart failure. Thus, identifying novel approaches toward regenerating the adult heart has enormous therapeutic potential for adult heart failure. Mitochondrial metabolism is an essential homeostatic process for maintaining growth and survival. The emerging role of mitochondrial metabolism in controlling cell fate and function is beginning to be appreciated. Recent evidence suggests that metabolism controls biological processes including cell proliferation and differentiation, which has profound implications during development and regeneration. The regenerative potential of the mammalian heart is lost by the first week of postnatal development when cardiomyocytes exit the cell cycle and become terminally differentiated. This inability to regenerate following injury is correlated with the metabolic shift from glycolysis to fatty acid oxidation that occurs during heart maturation in the postnatal heart. Thus, understanding the mechanisms that regulate cardiac metabolism is key to unlocking metabolic interventions during development, disease, and regeneration. In this review, we will focus on the emerging role of metabolism in cardiac development and regeneration and discuss the potential of targeting metabolism for treatment of heart failure.

Citing Articles

Cardiac Regeneration in Adult Zebrafish: A Review of Signaling and Metabolic Coordination.

Mitra A, Mandal S, Banerjee K, Ganguly N, Sasmal P, Banerjee D Curr Cardiol Rep. 2025; 27(1):15.

PMID: 39792206 DOI: 10.1007/s11886-024-02162-y.

Recent Insights into Endogenous Mammalian Cardiac Regeneration Post-Myocardial Infarction.

Fiorino E, Rossin D, Vanni R, Aubry M, Giachino C, Rastaldo R Int J Mol Sci. 2024; 25(21).

PMID: 39519298 PMC: 11546116. DOI: 10.3390/ijms252111747.

Spatial pattern and differential expression analysis with spatial transcriptomic data.

Qin F, Luo X, Lu Q, Cai B, Xiao F, Cai G Nucleic Acids Res. 2024; 52(21):e101.

PMID: 39470725 PMC: 11602167. DOI: 10.1093/nar/gkae962.

Glucocorticoid receptor antagonization propels endogenous cardiomyocyte proliferation and cardiac regeneration.

Pianca N, Sacchi F, Umansky K, Chirivi M, Iommarini L, Da Pra S Nat Cardiovasc Res. 2024; 1(7):617-633.

PMID: 39196236 DOI: 10.1038/s44161-022-00090-0.

Artificial Intelligence in Metabolomics: A Current Review.

Chi J, Shu J, Li M, Mudappathi R, Jin Y, Lewis F Trends Analyt Chem. 2024; 178.

PMID: 39071116 PMC: 11271759. DOI: 10.1016/j.trac.2024.117852.

References

Sanchez Canedo C, Demeulder B, Ginion A, Bayascas J, Balligand J, Alessi D . Activation of the cardiac mTOR/p70(S6K) pathway by leucine requires PDK1 and correlates with PRAS40 phosphorylation. Am J Physiol Endocrinol Metab. 2010; 298(4):E761-9. DOI: 10.1152/ajpendo.00421.2009. View

Kimball S, Shantz L, Horetsky R, Jefferson L . Leucine regulates translation of specific mRNAs in L6 myoblasts through mTOR-mediated changes in availability of eIF4E and phosphorylation of ribosomal protein S6. J Biol Chem. 1999; 274(17):11647-52. DOI: 10.1074/jbc.274.17.11647. View

Scialo F, Fernandez-Ayala D, Sanz A . Role of Mitochondrial Reverse Electron Transport in ROS Signaling: Potential Roles in Health and Disease. Front Physiol. 2017; 8:428. PMC: 5486155. DOI: 10.3389/fphys.2017.00428. View

Huang Y, Lei L, Liu D, Jovin I, Russell R, Johnson R . Normal glucose uptake in the brain and heart requires an endothelial cell-specific HIF-1α-dependent function. Proc Natl Acad Sci U S A. 2012; 109(43):17478-83. PMC: 3491491. DOI: 10.1073/pnas.1209281109. View

Wang Z, Ying Z, Bosy-Westphal A, Zhang J, Schautz B, Later W . Specific metabolic rates of major organs and tissues across adulthood: evaluation by mechanistic model of resting energy expenditure. Am J Clin Nutr. 2010; 92(6):1369-77. PMC: 2980962. DOI: 10.3945/ajcn.2010.29885. View

Li T, Zhang Z, Kolwicz Jr S, Abell L, Roe N, Kim M . Defective Branched-Chain Amino Acid Catabolism Disrupts Glucose Metabolism and Sensitizes the Heart to Ischemia-Reperfusion Injury. Cell Metab. 2017; 25(2):374-385. PMC: 5301464. DOI: 10.1016/j.cmet.2016.11.005. View

Nie C, He T, Zhang W, Zhang G, Ma X . Branched Chain Amino Acids: Beyond Nutrition Metabolism. Int J Mol Sci. 2018; 19(4). PMC: 5979320. DOI: 10.3390/ijms19040954. View

Talman V, Teppo J, Poho P, Movahedi P, Vaikkinen A, Karhu S . Molecular Atlas of Postnatal Mouse Heart Development. J Am Heart Assoc. 2018; 7(20):e010378. PMC: 6474944. DOI: 10.1161/JAHA.118.010378. View

Horton J, Davidson M, Kurishima C, Vega R, Powers J, Matsuura T . The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense. JCI Insight. 2019; 4(4). PMC: 6478419. DOI: 10.1172/jci.insight.124079. View

10.

Ritterhoff J, Tian R . Metabolism in cardiomyopathy: every substrate matters. Cardiovasc Res. 2017; 113(4):411-421. PMC: 5852620. DOI: 10.1093/cvr/cvx017. View

11.

Szablewski L . Glucose transporters in healthy heart and in cardiac disease. Int J Cardiol. 2016; 230:70-75. DOI: 10.1016/j.ijcard.2016.12.083. View

12.

Valls-Lacalle L, Barba I, Miro-Casas E, Ruiz-Meana M, Rodriguez-Sinovas A, Garcia-Dorado D . Selective Inhibition of Succinate Dehydrogenase in Reperfused Myocardium with Intracoronary Malonate Reduces Infarct Size. Sci Rep. 2018; 8(1):2442. PMC: 5799359. DOI: 10.1038/s41598-018-20866-4. View

13.

Poss K, Wilson L, Keating M . Heart regeneration in zebrafish. Science. 2002; 298(5601):2188-90. DOI: 10.1126/science.1077857. View

14.

Thorens B, Mueckler M . Glucose transporters in the 21st Century. Am J Physiol Endocrinol Metab. 2009; 298(2):E141-5. PMC: 2822486. DOI: 10.1152/ajpendo.00712.2009. View

15.

Xu X, Lu Z, Fassett J, Zhang P, Hu X, Liu X . Metformin protects against systolic overload-induced heart failure independent of AMP-activated protein kinase α2. Hypertension. 2014; 63(4):723-8. PMC: 4026291. DOI: 10.1161/HYPERTENSIONAHA.113.02619. View

16.

Milliken A, Kulkarni C, Brookes P . Acid enhancement of ROS generation by complex-I reverse electron transport is balanced by acid inhibition of complex-II: Relevance for tissue reperfusion injury. Redox Biol. 2020; 37:101733. PMC: 7527751. DOI: 10.1016/j.redox.2020.101733. View

17.

Montessuit C, Lerch R . Regulation and dysregulation of glucose transport in cardiomyocytes. Biochim Biophys Acta. 2012; 1833(4):848-56. DOI: 10.1016/j.bbamcr.2012.08.009. View

18.

Sack M, Kelly D . The energy substrate switch during development of heart failure: gene regulatory mechanisms (Review). Int J Mol Med. 1998; 1(1):17-24. DOI: 10.3892/ijmm.1.1.17. View

19.

Murphy S, Miyamoto M, Kervadec A, Kannan S, Tampakakis E, Kambhampati S . PGC1/PPAR drive cardiomyocyte maturation at single cell level via YAP1 and SF3B2. Nat Commun. 2021; 12(1):1648. PMC: 7955035. DOI: 10.1038/s41467-021-21957-z. View

20.

Wu R, Smeele K, Wyatt E, Ichikawa Y, Eerbeek O, Sun L . Reduction in hexokinase II levels results in decreased cardiac function and altered remodeling after ischemia/reperfusion injury. Circ Res. 2010; 108(1):60-9. PMC: 3017633. DOI: 10.1161/CIRCRESAHA.110.223115. View